A Phase I Safety Study of a Cancer Vaccine to Treat HLA-A2 Positive Advanced Stage Ovarian, Breast and Prostate Cancer

Clinical Trial ID NCT01095848

PubWeight™ 5.04^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01095848

Top papers